-
China clears more first-in-class innovative drugs than ever before
08 Apr 2025 01:00 GMT
China approved 48 first-in-class … released by China’s National Medical Products Administration.
BioWorld Regulatory Cancer Infection … Neurology/psychiatric Asia-Pacific China NMPA
-
China's maternal, infant, and under-5 mortality rates hit historic lows in 2024: NHC
08 Apr 2025 00:12 GMT
… Medical College Hospital in Beijing. Centered on the theme … elimination targets.
Since 2009, China has integrated cervical and breast cancer screenings into public health … to official data, 117 Chinese obstetricians, gynecologists, and pediatricians are …
-
Dr Zhang on the Rationale of Evaluating SIM0270/Everolimus in ER+/HER2– Advanced Breast Cancer
07 Apr 2025 23:34 GMT
… has an indication in China, but some inhibitors, … MD, of Fudan University Shanghai Cancer Center, details the rationale … everolimus is approved in China, certain treatments, such … HER2-negative advanced breast cancer, the combination demonstrated a …
-
Carbonxt (CG1) Managing Director Warren Murphy at the Ignite Investment Summit, 26-27 March 2025 Hong Kong
07 Apr 2025 15:03 GMT
Investor Insight
In an increasingly eco-conscious global market, Carbonxt makes a compelling investment case, leveraging a growing addressable market driven by regulatory changes and strategic partnerships. This addressable market is anticipated to grow …
-
Red State Bill Sparks MAHA Concerns About Alleged Chinese Poison Chemicals
07 Apr 2025 20:18 GMT
… Agency for Research on Cancer (IARC) said glyphosate … from the limited liability include Chinese chemical manufacturers. When ChemChina … American firm. However, China is still the primary producer … banned its use, including China. Sen. Watson, a …
-
China Market Update: China Readies Policies To Counter Tariffs
07 Apr 2025 17:57 GMT
… Mainland China and Hong Kong reopened following Friday’s market holiday and the Chinese … was a small net sell.
Shanghai, Shenzhen, and the STAR Board fell … :
New Drivers For China Healthcare: AI Med-Tech Innovation, Cancer Treatment, …
-
Shanghai Helioson Pharmaceutical divulges new GSPT1 degradation inducers
07 Apr 2025 17:57 GMT
Cancer
Shanghai Helioson Pharmaceutical Co. Ltd. has … useful for the treatment of cancer.
BioWorld Science Cancer Patents
-
Development of a Nomogram Integrating Modified Inflammation-Based Indexes for Predicting Overall Survival in Pancreatic Cancer: A Retrospective Study
07 Apr 2025 17:09 GMT
… immunosuppressive tumor microenvironment in pancreatic cancer. Cancer Discov. 2023;13(2):278 … resectable pancreatic head cancer? A consensus statement by the Chinese Study Group … for Pancreatic Cancer (CSPAC). Int j …
-
More Catholic clergy in China dying due to lifestyle diseases
07 Apr 2025 16:36 GMT
… diabetes (seven cases) and liver cancer (eight cases).
“While some … Chinese Catholic Patriotic Association (CCPA).
The Catholic Church in China … is primarily controlled by Beijing.
The largest number of … occasion of the annual Chinese Qing Ming Festival held …
-
Breakthrough Research Uncovers Tumor Tactics: How Cancer Cells Exploit Essential Nutrients to Escape Immune Surveillance
07 Apr 2025 16:02 GMT
… Chinese scientists, led by Prof. Hu Hai, reveals how breast cancer … provided.
Keywords: Arginine, Breast Cancer, Tumor Microenvironment, Immune Evasion, Tumor … in tumorsarginine metabolism in cancerbreast cancer researchcancer cell growth mechanismscancer …
About
© 1995-2025